|Trial start date||21 Oct 2011|
|Trial end date||15 Oct 2012|
|Sex||Female and Male|
|Age range||18 to 75 years|
A Phase III Multicenter, International, Randomized, Double-blind, Placebo-controlled Study of Doxorubicin Plus Palifosfamide-tris vs. Doxorubicin Plus Placebo in Patients With Front-line Metastatic Soft Tissue Sarcoma.
This trial is to evaluate the clinical efficacy of a drug known as palifosfamide-tris administered with doxorubicin in combination, compared with doxorubicin administered with placebo in front-line patients diagnosed with metastatic soft tissue sarcoma (STS)
|Hospital||Suburb / Town||Contact name||Phone||Recruitment status|
|Peter MacCallum Cancer Centre, Medical Oncology||East Melbourne||Ms Sam Ruellemail@example.com||03 9656 1111||Closed|